CD56NK

Yuxi Li1,2, Rui Cui1,2,3, Ying Yu1,2

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, People's Republic of China.

The oncologist
|March 10, 2025
PubMed
概括

在NK-大粒状淋巴细胞白血病 (NK-LGLL) 中CD56表达的减少与更严重的症状和侵袭性疾病有关. 这一发现强调了CD56作为NK-LGLL患者的关键预后标志物.